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Background: Eukaryotic translation initiation factor 4-gamma 1 (EIF4G1) gene mutations have recently been
reported in autosomal dominant, late-onset Parkinson’s disease (LOPD). We carried out genetic analysis to
determine the prevalence of EIF4G1 variants in an ethnic Chinese population and to better understand the
association between EIF4G1 and PD.
Methods: We conducted a comprehensive genetic analysis of EIF4G1 in a cohort of 29 probands of autosomal
dominant, LOPD families. Polymerase chain reaction (PCR) analysis and sequencing was carried out of the entire
EIF4G1 exonic regions and exon-intron boundaries. Specific mutation and exonic variants were chosen for further
sequencing in a case–control study including 503 sporadic PD and 508 healthy controls. Statistical significance was
analyzed by the Chi-square test.
Results: Our analysis revealed three exonic variants (rs2230571, rs13319149 and rs2178403) and eight intronic
variants across the entire EIF4G1 gene. No reported mutations were detected in EIF4G1 exonic regions. The
synonymous coding variant rs2230571 in exon 27 and the eight intronic variants were not used for further
sequencing, but the specific mutation c.3614G > A (p.R1205H) and the two nonsynonymous variants (rs13319149
and rs2178403) were chosen for further analysis in a case–control study. None of the 503 sporadic PD or 508
healthy controls carried p.R1205H, and there was no statistical significance in rs2178403 genotype or allele
frequencies in EIF4G1 between the PD cases and the healthy controls (p = 0.184 and p = 0.774, respectively;
Chi-square test). The rs13319149 genotype in all PD cases and healthy controls was GG.
Conclusions: Our data indicate that in an ethnic Chinese population, the pathogenic mutation p.R1205H in EIF4G1
is not common and that EIF4G1 exonic variants rs2178403 and rs13319149 are not associated with PD. EIF4G1 does
not appear to be a frequent cause of PD in this ethnic Chinese population.
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Parkinson’s disease (PD) is the second most common
neurodegenerative movement disorder and is clinically
characterized by the cardinal features of bradykinesia,
resting tremor, rigidity, postural instability and respon-
siveness to dopaminergic therapy. Most PD patients are
sporadic but approximately 5–10% are familial [1]. Al-
though the etiology of PD still remains elusive, certain
genes are known to influence PD susceptibility, for ex-
ample, autosomal dominant PD is associated with SNCA* Correspondence: xxyan1268@yahoo.com.cn
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reproduction in any medium, provided the or[2], LRRK2 [3], UCHL1 [4] and VPS35 [5,6], recessive
parkinsonism with PRKN [7], PINK1 [8] and DJ-1 [9],
and more complex forms of recessive parkinsonism with
ATP13A2 [10], PLA2G6 [11] and FBXO7 [12]. Several
techniques have been used to identify candidate genes in
familial PD, including classic linkage analysis, positional
cloning studies and recent exome sequencing [2,5,6,13].
Recently, Chartier-Harlin et al. [14,15] performed
genome-wide linkage analysis of a multi-incident French
family presenting with autosomal dominant, late-onset
PD (LOPD). They found that the mutation c.3614G >A
(p.R1205H) in EIF4G1, encoding eukaryotic translation
initiation factor 4G1 (eIF4G1), a component of the trans-
lation initiation complex eukaryotic translation initiation
factor 4F (eIF4F), caused the familial LOPD. The trans-his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 EIF4G1 gene variants in 29 probands of LOPD families
Exonic/intronic variants Accession number Nucleotide changea Amino acid change Frequency of variant in LOPD families (%)
1 Intron 2 rs73187631 IVS2-182 a > t 7.41
2 Intron 3 novel IVS3 -44 a > g 1.85
3 Intron 4 novel IVS4 + 115 g > a 3.70
4 Exon 7 rs13319149 c.481A > G T161A 100
5 Intron 9 rs9846954 IVS9 + 93 a > t 25.93
6 Intron 9 novel IVS9 + 75 indelb 7.41
7 Intron 9 rs4912537 IVS9-100 c > t 14.81
8 Exon 10 rs2178403 c.1294A > G M432V 55.56
9 Intron 15 1KG 3 184041398 IVS15 + 17 c > t 1.85
10 Intron 18 1KG 3 184043002 IVS18 + 100 g > t 1.85
11 Exon 27 rs2230571 c.4005C > T H1335H 18.52
a Human EIF4G1 cDNA sequence (RefSeq Accession number NM_198241.2) was used as the reference sequence.
b indel : acttgaac deletion; tgggtaccagagaa insertion. (i.e. acttgaac > ggtaccagagaa).
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ding eukaryotic translation initiation factor 4E (eIF4E) and
eukaryotic translation initiation factor 3e (eIF3e) that
interact with each other and conduct normal translation
initiation activity [14,18,19]. In the Chartier-Harlin study
[14], it was predicted that mutations p.A502V and
p.R1205H disrupt eIF4G1 binding to eIF4E or eIF3e,
resulting in PD. Subsequent sequencing and genotyping
analysis also identified different EIF4G1 mutations in af-
fected subjects with familial parkinsonism and idiopathic
Lewy body disease in different populations.
To obtain a comprehensive view of the prevalence of
EIF4G1 variants in an ethnic Chinese population, we
conducted a comprehensive genetic screening of EIF4G1
in a Han Chinese group of subjects.Methods
Patients
The study comprised 29 probands of PD families compat-
ible with autosomal dominant inheritance (two or more
PD cases in at least two consecutive generations) and 503
sporadic PD patients of Chinese Han ethnicity from
Hunan, Hubei, Jiangxi, Sichuan and Chongqing provinces
of China. All patients were consecutively recruited from
the Department of Neurology of Xiangya Hospital (Central
South University, State Key Laboratory of Medical GeneticsTable 2 Genotype and allele frequencies of rs2178403 in PD
N Genotype (%)
AA AG GG P
Patients 503 74(14.7) 226(44.9) 203(40.4) 0
Controls 508 87 (17.1) 210(41.4) 211(41.5)
P Values after correcting by binary logistic regression with age and gender using SPof China) and the Neurodegenerative Disorders Research
Center. A standard clinical neurological examination was
performed for all patients by two neurologists, and a diag-
nosis of idiopathic PD was made according to the United
Kingdom PD Brain Bank Criteria [20].
There were 13 male and 16 female PD patients among
the 29 autosomal dominant, LOPD probands, with a
mean age at onset of 50.33 ± 9.56 years (range, 41–
63 years). Of the 503 sporadic PD patients, 269 were
male and 234 were female with a mean age at onset of
55.25 ± 12.21 years (range, 22–81 years). The case–
control study also included 508 healthy controls (268
males and 240 females; average age at examination,
56.95 ± 15.20 years, range, 25–88 years) matched for age,
gender, ethnicity and area of residence. The control sub-
jects were healthy people from the Xiangya Hospital
Medical Center, and healthy volunteers with no history
of neurodegenerative diseases. A standard clinical neuro-
logical examination was performed on all control sub-
jects, and a diagnosis of possible idiopathic PD was
excluded according to the United Kingdom PD Brain
Bank Criteria. There was no statistically significant dif-
ference in age or gender between patients and controls
(p > 0.05, using Chi-square test). The study protocol was
approved by the Ethics Committee of Central South
University and written informed consent was obtained
from all patients and controls.and controls in Han Chinese
Allele (%)
value(df ) A G P value (df , OR)
.184a (1) 374(37.2) 632(62.8) 0.774b (1, 1.027)
384(37.8) 632(62.2)
SS 17.0: a p = 0.713, bp = 0.702.
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Genomic DNA was extracted from peripheral blood
using standard protocols. Polymerase chain reaction
(PCR) analysis was carried out using 20 primer pairs
(Additional file 1: Table S1, available online), and each
PCR product was purified and directly sequenced in both
forward and reverse directions on an ABI 3100 automated
sequencer (Applied Biosystems, Foster City, CA). We ini-
tially sequenced the entire EIF4G1 exonic regions and
exon-intron boundaries of the 29 probands of autosomal
dominant, LOPD. Sequence alignment and analysis were
carried out with Chromas 2.12 software (Technelysium
Pty, Inc., Queensland, Australia).
Statistical analysis
Allele and genotype frequencies of PD and control
groups were analyzed using the Chi-square test with
SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). A
two-tailed test p-value of <0.05 was considered statisti-
cally significant.
Results
We identified three exonic variants and eight intronic var-
iants across the entire EIF4G1 gene (Table 1). No reported
mutations were detected in the EIF4G1 exonic regions in
any of the 29 probands. One of the three exonic variants
(exon 25, rs2230571) was synonymous, the other two
(rs13319149 and rs2178403) were nonsynonymous.
Neither the synonymous variant nor the eight intronic
variants could be sequenced, but the specific mutation
p.R1205H and the two nonsynonymous variants under-
went sequencing analysis in the 503 sporadic PD patients
and 508 controls. None of the patients or controls carried
the specific mutation p.R1205H. The nonsynonymous ex-
onic variant rs2178403 was in Hardy-Weinberg equilib-
rium in both the patient and control groups using a
goodness-of-fit Chi-square test. Genotype and allele fre-
quencies of rs2178403 for all subjects are shown in Table 2.
No statistically significant differences were observed re-
garding rs2178403 genotype or allele frequency between
patients and controls (p = 0.184 and p = 0.774, respect-
ively). Regarding the nonsynonymous exonic variant
rs13319149, all patient and control genotypes were GG.
Discussion
EIF4G1 was confirmed as a candidate PD gene by
Chartier-Harlin et al. [14,15], but recently three other
groups identified EIF4G1 mutations in both PD patients
and healthy controls [21-23]. This raises questions about
the causality of the gene with regard to PD. In our com-
prehensive genetic analysis of EIF4G1, we also obtained
similar negative results. The specific mutation p.R1205H,
first identified by Chartier-Harlin, is important in PD for
regulating cell survival in response to stressors [14,15].However, it was absent from all of our 503 sporadic PD
cases and 508 healthy controls suggesting that different
populations may have different pathogenic mutations.
Alternatively, the effect of the same mutation may differ
in different populations, as indicated by the presence of
mutation p.R1205H in control individuals of a Central
European population shown by Schulte et al. [23].
In the present study, exonic variants rs13319149 and
rs2178403 showed no significant difference in either
genotype or allele frequencies between PD patients and
controls, suggesting that they are probably benign poly-
morphisms. Although EIF4G1 is considered a pathogenic
gene of LOPD, our 29 probands were not typical of
LOPD as the average age of onset was 50.33 ± 9.56 years.
This may contribute to our negative results, together
with the fact that our sample size was relatively small.
Further larger-scale genetic studies should therefore be
performed to validate our findings.
Conclusions
To our knowledge, this is the first study to assess the fre-
quency of EIF4G1 variants in a cohort of Chinese PD pa-
tients and controls. Our results suggest that in this ethnic
Chinese population, the pathogenic mutation p.R1205H in
EIF4G1 is not common and that nonsynonymous exonic
variants rs2178403 and rs13319149 are not associated
with PD. Thus, it appears that EIF4G1 is not a frequent
cause of PD in this ethnic Chinese population. Further
large scale genetic and functional studies would be useful
to establish EIF4G1 associations with PD.
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